Bodybuilders and others who wish to build muscle use Dindolyl Methane (or DIM). However there have been some recent links to health hazards that DIM can trigger. For instance, DIM can cause serious liver damage when consumed in excess. Kidney damage can also be a risk, and could lead to kidney failure. The possible long term health risks associated with DIM cause many athletes and bodybuilders ask the question: should I supplement my diet with an supplement with DIM?
The majority of people take diindolylmethane as a supplement to increase the production of testosterone. Testosterone is believed to function as an anandrogen, meaning that it can cause hormonal changes in tissues. DIM has been shown in studies to mimic the effects of testosterone, along with other hormones. Some manufacturers have added diindolylmethane (DIM) to their products to increase their appeal to males, as men produce more testosterone than women. Men will react to products that are similar to testosterone that is naturally produced.
Many companies market DIM as a tumor-suppressor. While diindolylmethane has been proven effective in reducing tumor growth in laboratory animals it was given orally to the animals. To achieve the same result diindolylmethane needs to be taken in high doses for an extended period of period of time. The animals studied did not show any symptoms of cancer for several years. However, they all developed liver diseases due to consuming too much diindolylmethane. For a thorough look at the way DIM is affecting the body, you should seek out a medical professional.
According to the US National Institute of Environmental Health Safety and Security, the only way to show that DIM is effective in treating breast cancer is to conduct an experiment where cells from healthy breast cancer cells are exposed to high doses of diindolylmethane for a long period of time. There are pros and negatives to using DIM as with any chemical. Its advantages include the capability to mimic hormones. This means that you could make insulin, which could inhibit cancer cell proliferation. The cons include the fact diindolylmethane is also able to produce a potentially harmful chemical called DMSO. Learn more about diindolylmethane dim now.
One of the most common claims for diindolylmethane to be a treatment for various health problems is that it acts as a natural, antibacterial, anti-fungal and anti-cancer agent. The National Institute of Health, through a thorough review of supportive data, concluded that there was no basis for these claims. According to the Institute of Chemical Technology, there was no research conducted to support this claim. The Institute of Chemical Safety, in their in-depth analysis of the safety profile for the firestone concluded that the data presented by pharmaceutical companies about the benefits of diindolylmethane for humans was not completely reliable.
Van der Goes, et. and. published their findings in a May 2021 issue of the Journal of Toxicology and Environmental Health. identified a variety of potential dangers that could be posed by the use of diindolylmethane, such as allergic reactions, skin rash, asthma attacks, dizziness, headaches, and respiratory issues. They also noted that the recommended daily dose for this chemical is 0.2 milligrams, which is about one 10th of one teaspoon. It isn’t known what the concentration is when this chemical is combined with other compounds. Because this substance has not been thoroughly tested, it cannot be considered safe at any level.
The abstract of the view indicates that the use of diindolylmethane (DIEM) in the treatment of cancer is based on the idea of blocking the intracellular inhibition of pyruvate metabolite by flavenoids, and thereby hindering the accumulation of oxalates in renal tubule cells as well as adenine granulocytes. The drug metabiplicate toxicology studies have not shown that this chemical is able to cause overdose. The Food and Drug Administration approved the substance as a prescription drug in June 1996. According to the FDA the company that manufactures firestone Tincture is currently completing two major trials in Europe and the United States.
The view abstract also indicates that the use of diindolylmethane (DIEM) in the treatment of cancer is based on the principal of blocking intracellular inhibition of pyruvate metabolite by flavenoids, and thus preventing accumulation of oxalates in renal tubule cells as well as Adenine granulocytes. However, the drug metabiplicate toxicology studies did not present convincing evidence that consumption of this chemical triggers an overdose. The Food and Drug Administration approved the substance as a prescription drug in June 1996. According to the FDA the manufacturer of firestone tincture is currently in the process of completing two major trials–one in Europe and another in the United States. According to FDA, the FDA states that the maker of firestone Tincture is currently conducting two major studies in Europe as well as one in the United States.